SCINAI IMMUNOTHERAPEUTICS LTD. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number of 510.43 million shares as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber · last filed 2026-04-01
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 510.43M shares.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 97.23M shares.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 98.49M shares.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 28.92M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number |
|---|---|
| 2025-12-31 | 510.43M shares 20-F · filed 2026-04-01 |
| 2024-12-31 | 97.23M shares 20-F · filed 2026-04-01 |
| 2023-12-31 | 98.49M shares 20-F · filed 2025-05-07 |
| 2022-12-31 | 28.92M shares 20-F · filed 2024-05-15 |